Entos Pharmaceuticals Inc. is a clinical-stage genetic medicines company. A new reality in genetic medicine lies ahead, one that will be ushered in with the advent of safe, effective, and redosable nucleic acid delivery technologies. At Entos, we develop next generation genetic medicines using our proprietary Fusogenix proteolipid vehicle (PLV) drug delivery system. Fusogenix PLVs are formulated with FAST proteins to enable the delivery of nucleic acid into target cells through direct fusion.
Company Details
- Employees
- 46
- Founded
- -
- Address
- 10230 Jasper Avenue, Unit 4550,united Kingdom
- in****@****rma.com
- Industry
- Biotechnology
- Website
- entospharma.com
- Keywords
- genetic medicine, Proteolipid Vehicles, Drug Delivery, Redosable, Nucleic Acid Payloads, Non-Toxic, Fusogenix, PLV.
- HQ
- Edmonton, Alberta
Entos Pharmaceuticals Questions
Entos Pharmaceuticals's website is entospharma.com
Entos Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/entospharmaceuticals
Entos Pharmaceuticals has
46 employees.
View email and phone details for 46
employees at Entos Pharmaceuticals.
Entos Pharmaceuticals's industry is
Biotechnology
Entos Pharmaceuticals's top competitors are
Syantra Inc.,
Nanostics Inc.,
Api,
Providence Therapeutics,
Nimble Science,
Fluid Biomed Inc.,
Iambic Therapeutics,
Future Fields,
Northern Rna Inc.,
Bioalberta.
Entos Pharmaceuticals's support email address is info@entospharma.com
Entos Pharmaceuticals's categories are Biotechnology
Entos Pharmaceuticals's founding year is 2016
